M&A Deal Summary |
|
---|---|
Date | 2023-12-14 |
Target | Applied BioMath |
Sector | Life Science |
Buyer(s) | Certara |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2008 |
Sector | Life Science |
Employees | 1,338 |
Revenue | 354M USD (2023) |
Certara engages in model-informed drug development and regulatory science, focused on optimizing drug development and improving health outcomes. Certara was founded in 2008 and is headquartered in Princeton, New Jersey.
DEAL STATS | # |
---|---|
Overall | 10 of 11 |
Sector (Life Science) | 2 of 2 |
Type (Add-on Acquisition) | 10 of 11 |
State (Massachusetts) | 2 of 2 |
Country (United States) | 6 of 6 |
Year (2023) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-01-04 |
Vyasa
Newburyport, Massachusetts, United States Vyasa provides scalable deep-learning software which allows life sciences organizations to perform predictions and answer complex questions across structured and unstructured bio-medical information. Vyasa was founded in 2017 and is based in Newburyport, Massachusetts. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-07-09 |
Chemaxon
Budapest, Hungary Chemaxon is a cheminformatics company that provides platforms, applications, and solutions to handle chemical entities in life sciences, biotechnology, agrochemicals, new materials, education, and other research industries. Chemaxon was formed in 1988 and is based in Budapest, Hungary. |
Buy | - |